Rigel Pharmaceuticals Cash Flow Statement (2010-2026) | RIGL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-13.79M	-20.95M	-22.61M	-27.45M	-13.49M	-19.04M	1.40M	-13.91M	-6.60M	-5.69M	0.01M	-8.25M	-1.03M	12.42M	14.34M	11.45M	59.61M	27.90M	268.06M	8.65M
Share-based Compensation (Quarter)	1.32M	0.27M	2.34M	0.94M	0.60M	2.71M	4.08M	0.00M	0.55M	0.01M	1.93M	0.09M	0.25M	0.16M	-10.31M	1.22M	0.42M	17.30M	2.75M
Deferred Taxes (Quarter)																				2.57M
Cash from Operations (Quarter)	55.22M	-10.30M	-19.09M	-25.64M	-12.91M	-13.30M	-21.91M	-4.07M	5.93M	-1.36M	-6.24M	-5.01M	0.30M	21.68M	14.50M	-0.89M	30.54M	24.03M	21.98M	2.73M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)	1.37M	0.89M	0.82M	0.68M
Depreciation & Amortization (CF) (Quarter)	0.26M	0.26M	0.40M	0.24M	0.24M	0.24M	0.28M	0.36M	0.30M	0.29M	0.29M	0.40M	0.61M	0.61M	0.60M	0.60M	0.61M	0.60M	0.60M	0.60M
Change in Working Capital
Change in Receivables (Quarter)	-124.82M	-2.38M	0.48M	-0.23M	1.96M	-1.67M	24.80M	-10.95M	-8.55M	2.73M	7.00M	-3.04M	1.39M	1.67M	11.04M	-0.07M	-1.64M	6.02M	5.84M	-1.82M
Change in Inventory (Quarter)	-0.11M	0.17M	-0.45M	0.11M	-0.59M	0.88M	1.98M	1.95M	-0.31M	-0.28M	-2.53M	2.31M	2.19M	-3.34M	-1.93M	-1.41M	8.37M	-0.19M	-1.13M	0.58M
Change in Account Payables (Quarter)	-3.42M	1.37M	0.70M	0.85M	-2.44M	0.59M	4.79M	-1.21M	-1.05M	2.76M	-0.86M	2.13M	-3.15M	-2.31M	-0.48M	0.61M	3.34M	-3.44M	3.35M	-2.71M
Change in Accured Expenses (Quarter)	-56.46M	-1.57M	1.23M	-4.06M	5.94M	-3.79M	3.63M	-3.21M	1.08M	0.67M	-0.75M	-3.43M	3.96M	4.03M	-3.10M	-2.95M	0.71M	2.17M	1.85M	-1.79M
Other Working Capital Changes (Quarter)	-1.67M	-0.67M	1.48M	2.00M	-1.48M	-1.78M	1.77M	-0.39M	-3.00M	-1.94M	3.27M	2.58M	-0.50M	1.40M	-0.04M	13.15M	-6.56M	1.87M	3.39M	3.79M
Investing Activities
Capital Expenditures (Quarter)	0.48M	0.17M	-0.50M	0.22M	-0.04M	-0.68M	0.94M	-0.10M	-0.00M	0.01M	0.03M
Sales of Property, Plant and Equipment (Quarter)						0.28M	0.35M	0.13M		0.02M	0.11M				0.07M
Change in Acquisitions & Divestments (Quarter)	17.90M	1.40M	30.85M	29.85M	20.80M	29.42M	21.17M	15.65M	11.75M	8.25M	6.00M	8.25M	18.70M	6.00M	6.75M	11.10M	15.75M	20.73M	13.55M	15.95M
Cash from Investing Activities (Quarter)	-49.66M	-44.40M	6.49M	22.63M	21.09M	10.46M	18.60M	0.78M	2.97M	-1.17M	-6.87M	0.31M	10.93M	3.80M	-10.91M	-10.55M	-23.28M	-33.17M	-25.36M	-7.97M
Financing Activities
Other financing activities (Quarter)	55.80M	-54.21M	1.08M	0.94M	0.60M		0.58M	0.00M	0.55M	0.01M	0.49M	0.09M	0.25M	0.16M	1.47M	0.48M	0.42M	4.27M	2.93M	0.32M
Cash from Financing Activities (Quarter)	59.22M	0.27M	1.08M	8.80M	-5.66M	5.51M	-2.10M	19.12M	-0.37M	-0.87M	0.49M	-2.51M	-0.75M	-9.84M	1.47M	0.48M	0.42M	4.27M	-4.57M	-10.92M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Change in Cash (Quarter)	64.78M	-54.42M	-11.51M	5.79M	2.52M	2.67M	-5.41M	15.83M	8.53M	-3.40M	-12.63M	-7.21M	10.48M	15.64M	5.05M	-10.96M	7.68M	-4.87M	-7.95M	-16.17M
Free Cash Flow (Quarter)	54.73M	-10.47M	-18.59M	-25.86M	-12.88M	-12.62M	-22.85M	-3.98M	5.93M	-1.37M	-6.27M	-5.01M	0.30M	21.68M	14.50M	-0.89M	30.54M	24.03M	21.98M	2.73M
Net Cash Flow (Quarter)	64.78M	-54.42M	-11.51M	5.79M	2.52M	2.67M	-5.41M	15.83M	8.53M	-3.40M	-12.63M	-7.21M	10.48M	15.64M	5.05M	-10.96M	7.68M	-4.87M	-7.95M	-16.17M

Research Tools

Developers

Rigel Pharmaceuticals Cash Flow Statement (2010-2026) | RIGL

Research Tools

Developers

Rigel Pharmaceuticals Cash Flow Statement (2010-2026) | RIGL

Create an account

Sign In

Reset Password